moxifloxacin has been researched along with Bile Duct Obstruction in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bang, KB; Kim, HJ; Kim, NH | 1 |
| Chamorro Mohedano, J; Díaz Souza, P; Puerto Alonso, JL; Rojas Martín, E | 1 |
| Grauer, M; Hahn, EG; Mühldorfer, S; Schwab, D | 1 |
2 trial(s) available for moxifloxacin and Bile Duct Obstruction
| Article | Year |
|---|---|
Prospective comparison of prophylactic antibiotic use between intravenous moxifloxacin and ceftriaxone for high-risk patients with post-ERCP cholangitis.
Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Ceftriaxone; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Cholestasis; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Prospective Studies | 2017 |
Biliary secretion of moxifloxacin in obstructive cholangitis and the non-obstructed biliary tract.
Topics: Aza Compounds; Bile; Biliary Tract; Cholangiopancreatography, Endoscopic Retrograde; Cholangitis; Cholestasis; Female; Fluoroquinolones; Humans; Injections, Intravenous; Male; Middle Aged; Moxifloxacin; Quinolines | 2005 |
1 other study(ies) available for moxifloxacin and Bile Duct Obstruction
| Article | Year |
|---|---|
[Fatal acute hepatitis and cholestasis associated with liver disease].
Topics: Acute Disease; Anti-Infective Agents; Aza Compounds; Chemical and Drug Induced Liver Injury; Cholestasis; Fatal Outcome; Fluoroquinolones; Humans; Liver Diseases, Alcoholic; Male; Middle Aged; Moxifloxacin; Quinolines | 2010 |